2023 Annual Meeting | C39 - Clinical Approach to Sleep Disorders

Date Sunday 04/23/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Logan D. Schneider, MD

Topic(s) Sleep

Learning Objectives Participants should become familiar with historical elements relevant in the assessment and management of hypersomnolence (vs hypersomnia), circadian rhythm disorders, and parasomnias; be able to educate their patients on healthy sleep-wake scheduling and behaviors; and be able to choose appropriate diagnostics, referrals, and first-line treatments for common sleep-wake disorders recognized in their patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:05 AM EST	Introduction	Introduction Logan D. Schneider, MD
07:05 AM - 07:40 AM EST	Speaker	How to Think About Your Sleepy Patient: Case and Discussion Logan D. Schneider, MD
07:40 AM - 08:15 AM EST	Speaker	Circadian Rhythms and Neurologic Diseases Michelle B. Jonelis, MD
08:15 AM - 08:50 AM EST	Speaker	Things That Go Bump in the Night: Exploring Parasomnias and Nocturnal Epilepsy Carlos Rodriguez, MD
08:50 AM - 09:00 AM EST	Discussion	Questions and Answers Logan D. Schneider, MD, Michelle B. Jonelis, MD

Faculty Disclosures
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Michelle B. Jonelis, MD	Dr. Jonelis has nothing to disclose.
Carlos Rodriguez, MD	Dr. Rodriguez has nothing to disclose.